Argentina | info:eu-repo/semantics/article
dc.creatorSantucci, Luca
dc.creatorFiorucci, Stefano
dc.creatorRubinstein, Natalia
dc.creatorMencarelli, Andrea
dc.creatorPallazzeti, Barbara
dc.creatorFederici, Barbara
dc.creatorRabinovich, Gabriel Adrián
dc.creatorMorelli, Antonio
dc.date.accessioned2018-02-11T22:32:51Z
dc.date.available2018-02-11T22:32:51Z
dc.date.created2018-02-11T22:32:51Z
dc.date.issued2003-05
dc.identifierSantucci, Luca; Fiorucci, Stefano; Rubinstein, Natalia; Mencarelli, Andrea; Pallazzeti, Barbara; et al.; Galectin-1 suppresses experimental colitis in mice; American Gastroenterological Association; Gastroenterology; 124; 5; 5-2003; 1381-1394
dc.identifier0016-5085
dc.identifierhttp://hdl.handle.net/11336/36410
dc.identifierCONICET Digital
dc.identifierCONICET
dc.description.abstractUncontrolled T-cell activation plays a critical role in the pathogenesis of inflammatory bowel diseases. Therefore, pharmacologic strategies directed to restore the normal responsiveness of the immune system by deleting inappropriately activated T cells could be efficacious in the treatment of these pathologic conditions. Galectin-1 is an endogenous lectin expressed in lymphoid organs that plays a role in the maintenance of central and peripheral tolerance. The aim of the present study was to evaluate the therapeutic effects of galectin-1 on T-helper cell type 1-mediated experimental colitis induced by intrarectal administration of 2,4,6-trinitrobenzene sulfonic acid (TNBS) in mice.
dc.languageeng
dc.publisherAmerican Gastroenterological Association
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0016508503002671
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/S0016-5085(03)00267-1
dc.relationinfo:eu-repo/semantics/altIdentifier/pmid/12730878
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectAutoimmune Colitis
dc.subjectGalectin-1
dc.subjectTumor Necrosis Factor Alpha
dc.subjectHuman Recombinant Galectin
dc.subjectIrritable Bowel Disease
dc.titleGalectin-1 suppresses experimental colitis in mice
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución